View Clinical Trial (Medical Research Study)
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
| City: |
|
Pittsburgh |
| State: |
|
Pennsylvania |
| Zip Code: |
|
15213 |
| Conditions: |
|
Schizophrenia - Schizoaffective Disorder - Delusional Disorder |
| Purpose: |
|
This preliminary study aims to investigate the mechanism of higher rates of type 2 diabetes
mellitus in patients with schizophrenia. As part of the study, we collect
neuroendocrine-immune data on patients with first episode, treatment naive psychosis,
patients with newly diagnosed schizophrenia and normal healthy controls.
Regardless the treatment status, we collect the same neuroendocrine-immune data on the
participants after 2 months.
|
| Study Summary: |
|
This preliminary study aims to investigate the mechanism of higher rates of type 2 diabetes
mellitus in patients with schizophrenia. As part of the study, we collect
neuroendocrine-immune data on patients with first episode, treatment naive psychosis,
patients with newly diagnosed schizophrenia and normal healthy controls.
Regardless the treatment status, we collect the same neuroendocrine-immune on the
participants (patients and controls) after 2 months. Thus, our study does not control
treatment. Patients take treatment in consultation with their physician. Some of them even
decide not to take any medications. At the 2nd visit, we do ask them about the the
medications they are taking if any.
|
| Criteria: |
|
Inclusion Criteria:
- Psychotic disorder as per DSM-IV criteria of the American Psychiatric Association
Exclusion Criteria:
- Diabetes, type 1 or 2
- Prominent substance abuse (i.e. psychotic symptoms attributable entirely to substance
use)
- Age above 50 or age below 14
|
| NCT ID: |
|
NCT00222807 |
| Primary Contact: |
|
Principal Investigator
Ripu D Jindal, MD
University of Pittsburgh
Ripu D Jindal, MD
Phone: 412 512 9516
Email: jindalr@upmc.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Pittsburgh, Pennsylvania 15213
United States
Richard S Guido, MD
Phone: 412-383-1480
Email: guidrs@upmc.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|